SCHEMBL29618341

SCHEMBL29618341

Nc1ccc2c(n1)CCO2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.46
MAPT P10636 3/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PRKCI P41743 1/20 0.34
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
MAP3K14 Q99558 1/20 0.33
CD274 Q9NZQ7 1/20 0.32
NOS2 P35228 2/20 0.31
NOS3 P29474 1/20 0.31
NOS1 P29475 1/20 0.31
PKM P14618 1/20 0.31
ITGB2 P05107 1/20 0.31
ICAM1 P05362 1/20 0.31
ITGAL P20701 1/20 0.31
PLAU P00749 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL126525 1.00 DYRK1A (0.46) DYRK1AMAPTRAB9ASMN1; SMN2PRKCI
SCHEMBL21935993 0.79 DYRK1A (0.35) DYRK1AMAPTRAB9ASMN1; SMN2PRKCI
SCHEMBL15435737 0.75 DYRK1A (0.39) DYRK1AMAPTRAB9ASMN1; SMN2PRKCI
SCHEMBL30848471 0.75 DYRK1A (0.35) DYRK1AMAPTRAB9ASMN1; SMN2PRKCI
SCHEMBL21333142 0.75 DYRK1A (0.35) DYRK1AMAPTRAB9ASMN1; SMN2PRKCI
SCHEMBL25768673 0.75 DYRK1A (0.35) DYRK1AMAPTRAB9ASMN1; SMN2PRKCI
SCHEMBL8103788 0.75 DYRK1A (0.36) DYRK1AMAPTRAB9ASMN1; SMN2PRKCI
SCHEMBL30540459 0.73 MAP3K14 (0.55) DYRK1AMAPTRAB9ASMN1; SMN2PRKCI
SCHEMBL23649681 0.73 MAP4K1 (0.38) DYRK1AMAPTALDH1A1GAANOS2
SCHEMBL30042104 0.73 MAP4K1 (0.38) DYRK1AMAPTALDH1A1GAANOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114591293-A Fused ring compound as Nav1.8 inhibitor and application thereof 成都康弘药业集团股份有限公司 2022-06-07 CN disclosed